Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Warts 2Neurofibromatosis 1 2Breast Neoplasms 2Stomatitis 1Retinoblastoma 1Retinal Neoplasms 1Prostatic Neoplasms 1Port-Wine Stain 1Pancreatic Neoplasms 1Osteoma, Osteoid 1Nevus of Ota 1Neurofibromatoses 1Neoplasms 1Mucositis 1Lymphedema 1Keratosis, Actinic 1Hemangioma, Capillary 1Cholangiocarcinoma 1Bile Duct Neoplasms 1Atrophy 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Lasers × Clear all
NCT04081805 2025-04-24

EPMLARF

Federal University of São Paulo

Phase NA Active not recruiting
195 enrolled
Breast

Atrophy, Breast Neoplasms

NCT00852930 2017-04-11

Low Level Laser Treatment and Breast Cancer Related Lymphedema

Vanderbilt University

Phase 4 Completed
50 enrolled 11 charts
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡